NASDAQ:EOLS
Evolus Inc. Stock Company Profile
$13.59
-0.110 (-0.80%)
At Close: May 17, 2024
Information
520 Newport Center Drive, Suite 1200
Newport Beach CA 92660
949 284 4555
www.evolus.com
Industry: Drug Manufacturers—Specialty & Generic
Sector: Healthcare
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.